ELGX - Endologix, Inc.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue192,925153,612147,588
Cost of Revenue69,13351,82141,801
Gross Profit123,792101,791105,787
Operating Expenses
Research Development32,33726,42121,616
Selling General and Administrative169,668123,212113,317
Non Recurring16,8615,0715,071
Total Operating Expenses---
Operating Income or Loss-95,074-52,913-29,146
Income from Continuing Operations
Total Other Income/Expenses Net-43,2646282,375
Earnings Before Interest and Taxes-138,338-52,285-26,771
Interest Expense15,8417,4765,709
Income Before Tax-154,179-59,761-32,480
Income Tax Expense498-9,337-62
Minority Interest---
Net Income From Continuing Ops-154,677-50,424-32,418
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-154,677-50,424-32,418
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-154,677-50,424-32,418